|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/513 | |
| A61K 31/517 | |||
| A61K 9/20 | |||
| A61P 31/18 |
| (11) | Patento numeris | 2586444 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12198385.2 |
| Europos patento paraiškos padavimo data | 2005-12-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 632944 P | 2004-12-03 | US |
| (72) |
Pourkavoos, Nazaneen, US
Ney, James, R., US
Cruanes, Maria, T., US
Wu, Yunhui, US
Palkar, Saurabh, A., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (54) | Pharmaceutical formulation of carboxamide HIV integrase inhibitors containing a release rate control composition |
| Pharmaceutical formulation of carboxamide HIV integrase inhibitors containing a release rate control composition |